1
|
Ibrahimli A, Aliyev A, Majidli A, Kahraman A, Galandarova A, Khalilzade E, Mammadli H, Huseynli K, Assaf K, Kilinc C, Muradov N, Alisan OF, Abdullayev S, Sahin YI, Samadov E. Metastasis to the stomach: a systematic review. F1000Res 2023; 12:1374. [PMID: 38706640 PMCID: PMC11066534 DOI: 10.12688/f1000research.140758.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 08/18/2023] [Indexed: 05/07/2024] Open
Abstract
Background: This study reviews the literature on gastric metastases (GM) in terms of diagnosis, treatment, and outcomes. The goal of this study was to provide clinicians with a reliable and beneficial source to understand gastric metastases arising from various primary tumors and to present the growing literature in an easily accessible form. Methods: Articles published in English language from implementation of MEDLINE and Cochrane databases until May 2022 were considered for the systematic review. Articles other than English language, letters to the editor, posters, and clinical images were excluded. Hematogenous and lymphogenic metastases were included whereas direct tumoral invasion and seeding were excluded. Articles and abstracts were analyzed and last selection was done after cross-referencing and by use of defined eligibility criteria. Results: In total 1,521 publications were identified and 170 articles were finally included totaling 186 patients with GM. The median age of patients was 62 years. Gynecologic cancer was the most common cancer type causing GM (67 patients), followed by lung cancer (33 patients), renal cancer (20 patients), and melanoma (19 patients). One of the main treatment methods performed for metastasis was resection surgery (n=62), sometimes combined with chemotherapy (ChT) or immunotherapy. ChT was the other most used treatment method (n=78). Also, immunotherapy was amongst the most preferred treatment options after surgery and ChT (n=10). Conclusions: As 172 case reports were screened in the systematic review from different journals, heterogeneity was inevitable. Some articles missed important information such as complete follow-up or clinical information. Moreover, since all of the included articles were case reports quality assessment could not be performed. Among 172 case reports reviewed, resection surgery was performed the most and was sometimes combined with ChT and immunotherapy. Further research about what type of treatment has the best outcomes for patients with gastric metastases is needed.
Collapse
|
2
|
Chen MY, Zarrin-Khameh N, Xu Y. Fine needle aspiration of pancreatic lesions focusing on secondary tumors with emphasis of metastatic breast cancer: A clinicopathological study with follow-up. Cancer Med 2023; 12:5485-5493. [PMID: 36281523 PMCID: PMC10028048 DOI: 10.1002/cam4.5374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Revised: 10/04/2022] [Accepted: 10/09/2022] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The data on metastatic tumors to the pancreas diagnosed by fine needle aspiration (FNA) biopsy is limited. We report our experience of FNA of primary and secondary pancreatic tumors emphasizing metastatic breast cancer in the pancreas. METHOD Total 274 cases of pancreatic FNA in 10 years were retrospectively reviewed. Literature review of metastatic breast cancers to the pancreas was performed. RESULTS Out of the 274 cases, 7 (7/274, 2.6%) cases were non-diagnostic, 46 (46/274, 16.8%) cases were negative for malignancy, and 40 (40/274, 14.6%) cases were under the category of atypical cells. There were 133 (133/274, 48.5%) cases diagnosed as positive for malignancy, 20 (20/274, 7.3%) suspicious for malignancy, and 28 (28/274, 10.2%) cases in the category of neoplastic: other. The most common neoplasm diagnosed was ductal adenocarcinoma (114/274, 41.6%; 114/133, 85.7% in positive for malignancy category). Ten cases (10/274, 3.7%) were diagnosed as metastatic neoplasms to the pancreas, including four breast infiltrating ductal carcinomas (IDC), one endocervical adenocarcinoma, one anal/rectal squamous cell carcinoma, one renal cell carcinoma, one hepatocellular carcinoma, one seminoma and one lung adenocarcinoma. We summarized the biomarkers of the four metastatic breast cancers and conducted literature review on biomarkers of metastatic breast cancers to the pancreas. CONCLUSIONS Upon analyzing FNAs of primary and secondary tumors in the pancreas, we have found breast carcinoma is the most common secondary pancreatic neoplasm in our patient population. Triple negative breast ductal carcinoma is the most common tumor among the metastasis of breast carcinomas to the pancreas. To the best of our knowledge, this study is the first report with a literature review focusing on biomarkers of metastatic breast cancer to the pancreas.
Collapse
Affiliation(s)
- Maria Yanqing Chen
- Department of Pathology & Immunology, Baylor College of Medicine, Texas, Houston, USA
| | - Neda Zarrin-Khameh
- Department of Pathology & Immunology, Baylor College of Medicine, Department of Pathology, Ben Taub Hospital, Harris Health System, Texas, Houston, USA
| | - Ya Xu
- Department of Pathology & Immunology, Baylor College of Medicine, Department of Pathology, Ben Taub Hospital, Harris Health System, Texas, Houston, USA
| |
Collapse
|
3
|
Kouhen F, Chihabeddine M, Squali M, Allaoui M, Bouzidi AA, Errafiy N, Ismaili N. Metastasis to the pancreas: a rare site for secondary malignancy of breast cancer (a case report). Pan Afr Med J 2020; 37:260. [PMID: 33598075 PMCID: PMC7864279 DOI: 10.11604/pamj.2020.37.260.25228] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2020] [Accepted: 11/09/2020] [Indexed: 11/11/2022] Open
Abstract
Breast cancer is the most frequent invasive cancer in women and the second cause of death by cancer in women after lung cancer. It causes metastases especially to bones, liver and lungs. Pancreatic metastases from a primary breast neoplasm are rare and unusual, occurring in less than 3% of the cases. There have been only 28 cases described in the literature. This paper adds one more case to the published literature. We present a case of pancreatic metastasis of the breast in a 64-year-old female and a discussion based on a review of the literature.
Collapse
Affiliation(s)
- Fadila Kouhen
- Mohammed VI University of Health Sciences (UM6SS), Department of Radiotherapy, International University Hospital Sheikh Khalifa, Casablanca, Morocco
| | - Meriem Chihabeddine
- Mohammed VI University of Health Sciences (UM6SS), Department of Radiotherapy, International University Hospital Sheikh Khalifa, Casablanca, Morocco
| | - Mohammed Squali
- Mohammed VI University of Health Sciences (UM6SS), Department of Medical Oncology, International University Hospital Sheikh Khalifa, Casablanca, Morocco
| | - Mohammed Allaoui
- Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.,Department of Pathology, Military Hospital Mohammed V, Rabat, Morocco
| | - Abderrahmane Al Bouzidi
- Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.,Department of Pathology, Military Hospital Mohammed V, Rabat, Morocco
| | - Nadia Errafiy
- Mohammed VI University of Health Sciences (UM6SS), National Reference Laboratory (LNR), Casablanca, Morocco
| | - Nabil Ismaili
- Mohammed VI University of Health Sciences (UM6SS), Department of Medical Oncology, International University Hospital Sheikh Khalifa, Casablanca, Morocco
| |
Collapse
|
4
|
S Prakash P, Lee JWK, Tang SW, Iau PTC. A rare case report of recurrent metastatic breast cancer mimicking primary pancreatic cancer. Int J Surg Case Rep 2020; 77:446-449. [PMID: 33395823 PMCID: PMC7691437 DOI: 10.1016/j.ijscr.2020.10.082] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2020] [Revised: 10/18/2020] [Accepted: 10/18/2020] [Indexed: 11/29/2022] Open
Abstract
Secondary pancreatic tumors are rare, of which a breast primary is extremely uncommon. Invasive lobular carcinoma is the commonest breast cancer histological subtype metastasizing to the pancreas. Imaging characteristics can usually adequately differentiate secondary from primary pancreatic tumors. Pancreatic metastasectomy offers reasonably good long-term survival rates and can even be curative in selected cases.
Introduction Secondary pancreatic tumors are rare, of which a breast cancer primary is extremely uncommon. To our knowledge, we present the 14th case reported worldwide and first from Singapore of lobular breast cancer metastasizing to the pancreas. Presentation of case A 53-year-old woman presented with painless obstructive jaundice, weight loss over 1.5 months and a 2 cm right breast mass. She had left breast Invasive Lobular Carcinoma (ILC) treated 5 years prior with wide local excision, adjuvant radiotherapy and hormonal therapy. She had elevated bilirubin, liver enzymes and Cancer Antigen (CA) 19–9. Imaging found 3 right breast nodules, left axillary lymphadenopathy, biliary dilatation with an ampullary mass, and bone metastases. Breast nodule biopsies confirmed ILC but ampullary mass cytopathology was inconclusive. Frozen section of the mass during exploratory laparotomy showed metastatic ILC; a triple bypass surgery was done and chemo-endocrine therapy commenced. Discussion ILC is the commonest type of breast carcinoma in cases with pancreatic metastases, usually recurring after long disease-free intervals, and widely metastatic at presentation. Imaging characteristics help differentiate secondary from primary pancreatic tumors. Radiological features and history of an extra-pancreatic cancer suffice in suspecting pancreatic metastases. Despite limited surgical experience, it is well accepted that pancreatic metastasectomy offers reasonably good long-term survival rates, quality of life and can even be curative in highly selected cases. Conclusion This case is an interesting case because it highlights the diagnostic dilemma involved in the rare entity of breast cancer metastatic to the pancreas, and summarizes its diagnosis and management.
Collapse
Affiliation(s)
- Prajwala S Prakash
- Division of Breast Surgery, University Surgical Cluster, National University Health System (NUHS), 5 Lower Kent Ridge Road, Singapore, 119074, Singapore.
| | - James Wai Kit Lee
- Division of Breast Surgery, University Surgical Cluster, National University Health System (NUHS), 5 Lower Kent Ridge Road, Singapore, 119074, Singapore
| | - Siau Wei Tang
- Division of Breast Surgery, University Surgical Cluster, National University Health System (NUHS), 5 Lower Kent Ridge Road, Singapore, 119074, Singapore
| | - Philip Tsau Choong Iau
- Division of Breast Surgery, University Surgical Cluster, National University Health System (NUHS), 5 Lower Kent Ridge Road, Singapore, 119074, Singapore
| |
Collapse
|
5
|
EUS-FNA Diagnosis with Core Biopsy of Pancreatic Metastases from Primary Breast Cancer. Case Rep Gastrointest Med 2020; 2020:7136897. [PMID: 33014479 PMCID: PMC7516693 DOI: 10.1155/2020/7136897] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Revised: 07/30/2020] [Accepted: 09/06/2020] [Indexed: 11/17/2022] Open
Abstract
Background The pancreas as a site of metastasis of other primary tumors is a rare event. Pancreatic metastases may occur years after the start of treatment of a neoplasm of another organ or may be the initial manifestation of an unidentified primary tumor. The most commonly reported primary sites for pancreatic metastases are the kidneys, lungs, breast, bowel, and skin (melanoma). Case Summary. The authors report a case of pancreatic metastasis derived from a primary breast cancer that underwent endoscopic ultrasound fine-needle aspiration (EUS-FNA) core biopsy to obtain tissue, which made it possible to perform an immunohistochemical study. Conclusion We emphasize the importance of outpatient follow-up after the treatment of a neoplasia and the completion of control exams. In addition, we should always be aware of the finding of a secondary lesion in patients who have already been diagnosed with cancer, even if it is located in unusual organs, as in this case, where two metastases of a breast carcinoma to the pancreas were detected.
Collapse
|
6
|
Derouane F, Yombi JC, Baurain JF, Danse E, Komuta M, Yildiz H. When a metastatic breast cancer is mimicking a pancreatic cancer: case report and review of the literature. Acta Clin Belg 2020; 75:301-307. [PMID: 31035903 DOI: 10.1080/17843286.2019.1607990] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
We report the case of a 51 year-old female who complained of jaundice and weight loss. At the time of presentation, she had been in remission from a stage 2a ductal breast carcinoma for 58 months. The clinical presentation was suggestive of a primary pancreas cancer with liver metastases and retroperitoneal lymph nodes. We performed liver and pancreas biopsies that demonstrate a relapse of her old breast carcinoma with positive hormone receptors and HER2 positive. Conservative treatment by chemotherapy was given with Paclitaxel - Trastuzumab and Pertuzumab. Pancreatic metastases are uncommon. Furthermore, pancreatic metastases from breast cancer are very rare. We performed a review of the literature and found 48 cases of pancreatic metastases from breast cancer. We would like to highlight by this case that when a pancreatic lesion appears, in patients with a past history of cancer, physicians must not forget the possibility of metastases from primary tumor even if the initial stage, of the tumor, is low. However the diagnosis is not always easy. If liver and pancreatic lesions occur simultaneously, the clinical presentation can mimic metastatic primary pancreatic cancer. Therefore performing biopsy is highly recommended for making the correct diagnosis and also for the staging of the disease and the choice of the best treatment according to immunohistochemical analysis.
Collapse
Affiliation(s)
- Françoise Derouane
- Department of internal medicine, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
| | - Jean-Cyr Yombi
- Department of internal medicine, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
| | - Jean-François Baurain
- Department of oncology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
| | - Etienne Danse
- Department of Radiology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
| | - Mina Komuta
- Department of anatomopathology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
| | - Halil Yildiz
- Department of internal medicine, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
| |
Collapse
|
7
|
Khalid S, Paniz G, Abbass A, Fischer E, Parasher G, McCarthy D. A Rare Site of Spread of a Common Cancer. Dig Dis Sci 2019; 64:3096-3099. [PMID: 31628573 DOI: 10.1007/s10620-019-05898-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
Affiliation(s)
- Sameen Khalid
- Division of Gastroenterology, University of New Mexico School of Medicine, Albuquerque, NM, USA. .,Division of Gastroenterology and Hepatology, University of New Mexico, MSC 10-5550, Albuquerque, NM, 87131, USA.
| | - Graziella Paniz
- Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA
| | - Aamer Abbass
- Division of Gastroenterology, University of New Mexico School of Medicine, Albuquerque, NM, USA
| | - Edgar Fischer
- Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA
| | - Gulshan Parasher
- Division of Gastroenterology, University of New Mexico School of Medicine, Albuquerque, NM, USA
| | - Denis McCarthy
- Division of Gastroenterology, University of New Mexico School of Medicine, Albuquerque, NM, USA
| |
Collapse
|
8
|
Liu H, Wang S, Zhou S, Meng Q, Ma X, Song X, Wang L, Jiang W. Drug Resistance-Related Competing Interactions of lncRNA and mRNA across 19 Cancer Types. MOLECULAR THERAPY. NUCLEIC ACIDS 2019; 16:442-451. [PMID: 31048183 PMCID: PMC6488743 DOI: 10.1016/j.omtn.2019.03.011] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Revised: 03/24/2019] [Accepted: 03/24/2019] [Indexed: 12/13/2022]
Abstract
Drug resistance is a common cause of treatment failure in cancer therapy, and molecular mechanisms need further exploration. Competing endogenous RNAs (ceRNAs) can influence drug response by participating in various biological processes, including regulation of cell cycle, signal transduction, and so on. In this study, we systematically explored resistance from the perspective of ceRNA modules. First, we constructed a general ceRNA network, involving 83 long non-coding RNAs (lncRNAs) and 379 mRNAs. Next, we identified the drug resistance-related modules for 138 drugs and 19 cancer types, totaling 758 drug-cancer conditions. Function analysis showed that resistance-related biological processes were enriched in these modules, such as regulation of cell proliferation, DNA damage repair, and so on. Pan-drug and pan-cancer analyses revealed some common and specific modules across multiple drugs or cancers. In addition, we also found that drug pairs with common modules have similar structure, indicating high risk for multidrug resistance (MDR). Finally, we speculated that ceRNA pair GAS5-RPL8 could regulate drug resistance because low expression of GAS5 would enhance microRNA (miRNA)-mediated inhibition of RPL8. In total, we investigated the drug resistance by using ceRNA modules and proposed that ceRNA modules may be new markers for drug resistance that indicated a possible novel mechanism.
Collapse
Affiliation(s)
- Haizhou Liu
- College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 211106, China
| | - Shuyuan Wang
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China
| | - Shunheng Zhou
- College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 211106, China
| | - Qianqian Meng
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China
| | - Xueyan Ma
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China
| | - Xiaofeng Song
- College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 211106, China.
| | - Lihong Wang
- Department of Pathophysiology, School of Medicine, Southeast University, Nanjing 210009, China.
| | - Wei Jiang
- College of Automation Engineering, Nanjing University of Aeronautics and Astronautics, Nanjing 211106, China.
| |
Collapse
|